Welcome to our dedicated page for Ibex SEC filings (Ticker: IBEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the story behind IBEX’s rapid expansion into AI-powered contact centers? Start with the disclosures investors trust most. Our SEC Filings hub untangles every IBEX document—whether you need the IBEX annual report 10-K simplified to gauge client concentration risk or an IBEX quarterly earnings report 10-Q filing to track segment margins.
Finding those details across hundreds of pages is tedious. Stock Titan applies AI that highlights wage inflation in nearshore sites, flags capital spending on the Wave iX platform, and provides instant alerts for IBEX insider trading Form 4 transactions. The result: understanding IBEX SEC documents with AI becomes a five-minute task.
Use the menu to jump straight to what professionals ask for most:
- Real-time Form 4 feed – follow IBEX executive stock transactions Form 4 and get context around each trade.
- 8-K event briefs – see IBEX 8-K material events explained minutes after they hit EDGAR, from new client wins to leadership changes.
- DEF 14A proxy tools – decode IBEX proxy statement executive compensation without spreadsheet gymnastics.
- Earnings pack – one click reveals our IBEX earnings report filing analysis and historical KPIs.
Every filing—10-K, 10-Q, 8-K, S-8, SC 13G, or the next IBEX Form 4 insider transactions real-time—arrives here within seconds of EDGAR publication and is paired with plain-English summaries. Monitor contract renewal clauses, compare headcount by region, or assess AI capital spend—all without sifting through dense legal text. Complex disclosures, made clear.
Form 144 filed for IBEX Ltd (IBEX) reports a proposed sale of 844 shares of common stock valued at $32,494 with an approximate sale date of 09/16/2025 on NASDAQ. The shares were acquired by the seller as a stock grant from the issuer on 07/01/2025 (1,210 shares acquired in that grant). The filing also discloses a prior disposal by the same person of 366 shares on 08/26/2025 for gross proceeds of $10,660.39. The filer certifies they have no material nonpublic information about the issuer.
Insider sale by IBEX Ltd CFO to satisfy tax withholding from RSU vesting. Taylor C. Greenwald, listed as Chief Financial Officer, reported a sale of 438 common shares on 08/26/2025 at a price of $29.13 per share. The filing states the shares were sold to cover tax withholding obligations related to the vesting of restricted stock units and were not discretionary trades. After the transaction, the reporting person beneficially owned 35,856 shares, held directly. The Form 4 was signed by an attorney-in-fact, Lisa Lenstrohm, on 09/15/2025.
IBEX Ltd. insider sale reported: Paul Joseph Inson, listed as Chief People Officer, reported a sale of 3,831 common shares on 09/12/2025 at a price of $38.94 per share. Following the sale, the filing shows Mr. Inson beneficially owns 3,266 shares. The Form 4 was signed by an attorney-in-fact on 09/15/2025. The document contains no additional explanation of the reason for the sale or any derivative transactions.
Paul Joseph Inson, Chief People Officer of IBEX Ltd (IBEX), reported a sale of shares to satisfy tax-withholding obligations related to vested restricted stock units. The Form 4 shows a sale of 255 common shares on 08/26/2025 at a price of $29.13 per share. After the sale, the reporting person beneficially owns 7,097 shares in a direct ownership form. The filing states the sale was executed to cover tax withholding and not as a discretionary trade by the reporting person. The form was filed individually and was signed by an attorney-in-fact on 09/15/2025.
IBEX Ltd reporting person Julie K. Casteel sold 295 common shares at $29.13 per share on 08/26/2025 to cover tax withholding on vested restricted stock units. After the sale the reporting person beneficially owned 30,895 shares, held directly. The Form 4 indicates the sales were required to satisfy tax obligations and were not discretionary trades, signaling they were routine administrative transactions related to equity compensation rather than a change in investment view.
IBEX Ltd insider Christina Alice Trofimuk-O'Connor, identified as the company's Chief Legal Officer and a director, reported a sale of 366 common shares on 08/26/2025 at $29.13 per share. After the transaction she beneficially owned 12,571 shares directly. The filing states the sale was executed to satisfy tax withholding obligations arising from the vesting of restricted stock units and was not a discretionary trade. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person. All details above are taken directly from the submitted Form 4.
David Martin Afdahl, Chief Operating Officer of IBEX Ltd (IBEX), reported a non-discretionary sale of 403 common shares on 08/26/2025 at $29.13 per share. The filing states the sale was required to cover tax withholding arising from the vesting of restricted stock units and not a discretionary trade. After the transaction, the reporting person beneficially owned 54,986 common shares directly. The Form 4 was filed as a single-person filing and is signed by an attorney-in-fact.
Bruce Neil Dawson, a director and the company's Chief Sales and CS Officer, reported a sale of 350 common shares of IBEX Ltd on 08/26/2025 at an average price of $29.13 per share. The sale was made to satisfy tax withholding obligations arising from the vesting of restricted stock units and is described as required, not a discretionary trade. After the transaction the reporting person beneficially owned 5,257 shares. The Form 4 was filed as an individual report and signed by an attorney-in-fact.
IBEX Limited reported revenue of $558.3 million for the fiscal year ended June 30, 2025, a 9.8% increase over the prior year, and net income of $36.9 million, up 9.5% from $33.7 million. The company attributed growth to new client wins, expansion in offshore and nearshore capacity, and revenue gains in Retail & E-commerce, HealthTech, Travel, Transportation & Logistics, while FinTech and Telecommunications declined. Fully diluted EPS rose to $2.36 from $1.84, helped by higher net income and fewer diluted shares outstanding.
IBEX operates a global delivery model with 30 centers and approximately 33,000 employees as of June 30, 2025, derives 96% of revenue from U.S. customers, and notes concentration risk with its top three clients representing 26% of revenue and the top client about 11%. Management emphasizes a technology-led strategy built around the Wave iX platform and AI initiatives, while disclosing material risks including client concentration, seasonality, cybersecurity, regulatory and tax considerations, debt covenants, and dependence on third-party telecom and internet channels.
FAQ
What is the current stock price of Ibex (IBEX)?
What is the market cap of Ibex (IBEX)?
